Key facts
- It has raised $2.2M across 2 recorded rounds; the latest was Seed Round ($690K) in Jul 2022.
- Notable investors include United States Department of War.
- MR3 Health has filed 8 Form Ds with the SEC since 2015, most recently Nov 2025 ($690K sold to 8 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MR3 Health
Funding rounds
2 roundsAbout MR3 Health
Developer of disease prevention technology designed to treat diabetes at a lower cost. The company's technology saves lives affected by diabetic neuropathy through their remote patient monitoring to help them with chronic conditions and to help prevent diabetic foot ulcers, enabling patients to recover from diabetes and lower the costs of healthcare.
- Sector
- Healthcare
- HQ
- San Antonio, TX, United States
- Founded
- 2014
- Employees
- 12
- Website
- mr3health.com/
- Ownership
- Privately Held (backing)
MR3 Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MR3 Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MR3 Health in its N-PORT filings yet. We sweep new filings monthly.